Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Axis NIFTY Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited17.7913217233.4633
Domestic EquitiesCipla Limited8.9536115941.7429
Domestic EquitiesMax Healthcare Institute Limited8.7733153211.7078
Domestic EquitiesApollo Hospitals Enterprise Limited7.928120831.5433
Domestic EquitiesDr. Reddy's Laboratories Limited7.8943125581.5367
Domestic EquitiesDivi's Laboratories Limited7.651826181.4895
Domestic EquitiesFortis Healthcare Limited5.3501107391.0415
Domestic EquitiesLupin Limited4.896549870.9532
Domestic EquitiesTorrent Pharmaceuticals Limited3.990821560.7769
Domestic EquitiesLaurus Labs Limited3.463480090.6742
Domestic EquitiesAlkem Laboratories Limited3.218911550.6266
Domestic EquitiesAurobindo Pharma Limited3.212257690.6253
Domestic EquitiesGlenmark Pharmaceuticals Limited3.115731060.6065
Domestic EquitiesMankind Pharma Limited2.909123250.5663
Domestic EquitiesZydus Lifesciences Limited2.597751500.5057
Domestic EquitiesBiocon Limited2.1724124010.4229
Domestic EquitiesIPCA Laboratories Limited1.971428660.3838
Domestic EquitiesAbbott India Limited1.61001070.3134
Domestic EquitiesSyngene International Limited1.250439080.2434
Domestic EquitiesPiramal Pharma Limited1.1545117560.2247
Total 99.9056 19.4478
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd0.2194 0.0427
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1249 -0.0243
Total 0.0944 0.0184
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.